Functional status, lymphocyte-to-monocyte ratio, and platelet-to-lymphocyte ratio as prognostic factors of one-year survival rate in elderly patients with advanced-stage non-small cell lung cancer

Background and aim: Non-small cell lung cancer (NSCLC) is the most common lung cancer found in elderly patients. Aging and chronic inflammation are related to its pathogenesis. Functional status, lymphocyte-to-monocyte ratio and platelet-to-lymphocyte ratio describe a chronic inflammation and correl...

Full description

Saved in:
Bibliographic Details
Main Authors: Ratna Nurhayati, Aulia Rizka, Cleopas Martin Rumende, Noorwati Sutandyo, Arif Hanafi, Edy Rizal Wahyudi, Hamzah Shatri, Anna Mira Lubis, Em Yunir, Muhammad Firdaus, Yuniar Harris Prayitno, Nadira Nibras Taqiyya
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:Cancer Treatment and Research Communications
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2468294224000716
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823864213755396096
author Ratna Nurhayati
Aulia Rizka
Cleopas Martin Rumende
Noorwati Sutandyo
Arif Hanafi
Edy Rizal Wahyudi
Hamzah Shatri
Anna Mira Lubis
Em Yunir
Muhammad Firdaus
Yuniar Harris Prayitno
Nadira Nibras Taqiyya
author_facet Ratna Nurhayati
Aulia Rizka
Cleopas Martin Rumende
Noorwati Sutandyo
Arif Hanafi
Edy Rizal Wahyudi
Hamzah Shatri
Anna Mira Lubis
Em Yunir
Muhammad Firdaus
Yuniar Harris Prayitno
Nadira Nibras Taqiyya
author_sort Ratna Nurhayati
collection DOAJ
description Background and aim: Non-small cell lung cancer (NSCLC) is the most common lung cancer found in elderly patients. Aging and chronic inflammation are related to its pathogenesis. Functional status, lymphocyte-to-monocyte ratio and platelet-to-lymphocyte ratio describe a chronic inflammation and correlate to the survival of older adults with advanced-stage (IIIB-IV) NSCLC. This study aims to determine functional status, lymphocyte-to-monocyte ratio and platelet-to-lymphocyte ratio as prognostic factors to 1-year survival in elderly patients with NSCLC stage IIIB-IV. Methods: Survival analysis with a cohort retrospective study is conducted on elderly patients with NSCLC stage IIIB-IV in Dharmais National Cancer Center Hospital between January 2020 and June 2022. Medical records were collected, comprising complete blood count prior to chemotherapy or radiotherapy, assessment of functional status through the Barthel Index for Activities of Daily Living (ADL), and 1-year survival post-diagnosis. Factors potentially influencing outcomes included diabetes mellitus, anemia, chronic obstructive pulmonary disease, and chronic kidney disease. Statistical analyses were performed using SPSS 20.0, employing the log-rank method for bivariate analysis and Cox regression for multivariate analysis. Results: In a cohort of 108 patients, the majority were aged 60–69 years (74.1 %), male (66.7 %), diagnosed at stage IV (80.5 %), and with adenocarcinoma subtype (75.0 %). Significant correlations were observed between the lymphocyte-to-monocyte ratio and platelet-to-lymphocyte ratio with the 1-year survival rate in elderly patients with stage IIIB-IV NSCLC (p = 0.015 and p = 0.001, respectively). Functional status did not show a significant correlation with 1-year survival overall (p = 0.540), but significant correlations were noted in patients receiving chemotherapy (p = 0.044) and radiotherapy (p = 0.009). Conclusion: The lymphocyte-to-monocyte ratio and platelet-to-lymphocyte ratio provide significant prognostic insights regarding 1-year survival in elderly patients diagnosed with stage IIIB-IV non-small cell lung cancer (NSCLC). In contrast, the functional status of these patients does not demonstrate a significant correlation with one-year survival.
format Article
id doaj-art-085b57a7745740b3ad4f3594ed48183f
institution Kabale University
issn 2468-2942
language English
publishDate 2024-01-01
publisher Elsevier
record_format Article
series Cancer Treatment and Research Communications
spelling doaj-art-085b57a7745740b3ad4f3594ed48183f2025-02-09T05:00:46ZengElsevierCancer Treatment and Research Communications2468-29422024-01-0142100859Functional status, lymphocyte-to-monocyte ratio, and platelet-to-lymphocyte ratio as prognostic factors of one-year survival rate in elderly patients with advanced-stage non-small cell lung cancerRatna Nurhayati0Aulia Rizka1Cleopas Martin Rumende2Noorwati Sutandyo3Arif Hanafi4Edy Rizal Wahyudi5Hamzah Shatri6Anna Mira Lubis7Em Yunir8Muhammad Firdaus9Yuniar Harris Prayitno10Nadira Nibras Taqiyya11Dharmais National Cancer Center Hospital, Jakarta, Indonesia; Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Corresponding author.Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Dr. Cipto Mangunkusumo National Central Public Hospital, Jakarta, IndonesiaFaculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Dr. Cipto Mangunkusumo National Central Public Hospital, Jakarta, IndonesiaDharmais National Cancer Center Hospital, Jakarta, Indonesia; Faculty of Medicine, Universitas Indonesia, Jakarta, IndonesiaDharmais National Cancer Center Hospital, Jakarta, IndonesiaFaculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Dr. Cipto Mangunkusumo National Central Public Hospital, Jakarta, IndonesiaFaculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Dr. Cipto Mangunkusumo National Central Public Hospital, Jakarta, IndonesiaFaculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Dr. Cipto Mangunkusumo National Central Public Hospital, Jakarta, IndonesiaFaculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Dr. Cipto Mangunkusumo National Central Public Hospital, Jakarta, IndonesiaMinistry of Health of the Republic of Indonesia, Jakarta, IndonesiaDharmais National Cancer Center Hospital, Jakarta, IndonesiaDharmais National Cancer Center Hospital, Jakarta, IndonesiaBackground and aim: Non-small cell lung cancer (NSCLC) is the most common lung cancer found in elderly patients. Aging and chronic inflammation are related to its pathogenesis. Functional status, lymphocyte-to-monocyte ratio and platelet-to-lymphocyte ratio describe a chronic inflammation and correlate to the survival of older adults with advanced-stage (IIIB-IV) NSCLC. This study aims to determine functional status, lymphocyte-to-monocyte ratio and platelet-to-lymphocyte ratio as prognostic factors to 1-year survival in elderly patients with NSCLC stage IIIB-IV. Methods: Survival analysis with a cohort retrospective study is conducted on elderly patients with NSCLC stage IIIB-IV in Dharmais National Cancer Center Hospital between January 2020 and June 2022. Medical records were collected, comprising complete blood count prior to chemotherapy or radiotherapy, assessment of functional status through the Barthel Index for Activities of Daily Living (ADL), and 1-year survival post-diagnosis. Factors potentially influencing outcomes included diabetes mellitus, anemia, chronic obstructive pulmonary disease, and chronic kidney disease. Statistical analyses were performed using SPSS 20.0, employing the log-rank method for bivariate analysis and Cox regression for multivariate analysis. Results: In a cohort of 108 patients, the majority were aged 60–69 years (74.1 %), male (66.7 %), diagnosed at stage IV (80.5 %), and with adenocarcinoma subtype (75.0 %). Significant correlations were observed between the lymphocyte-to-monocyte ratio and platelet-to-lymphocyte ratio with the 1-year survival rate in elderly patients with stage IIIB-IV NSCLC (p = 0.015 and p = 0.001, respectively). Functional status did not show a significant correlation with 1-year survival overall (p = 0.540), but significant correlations were noted in patients receiving chemotherapy (p = 0.044) and radiotherapy (p = 0.009). Conclusion: The lymphocyte-to-monocyte ratio and platelet-to-lymphocyte ratio provide significant prognostic insights regarding 1-year survival in elderly patients diagnosed with stage IIIB-IV non-small cell lung cancer (NSCLC). In contrast, the functional status of these patients does not demonstrate a significant correlation with one-year survival.http://www.sciencedirect.com/science/article/pii/S2468294224000716Non-small-cell lung carcinomaGeriatricElderlyFunctional statusLymphocyte-to-monocyte ratioPlatelet-to-lymphocyte ratio
spellingShingle Ratna Nurhayati
Aulia Rizka
Cleopas Martin Rumende
Noorwati Sutandyo
Arif Hanafi
Edy Rizal Wahyudi
Hamzah Shatri
Anna Mira Lubis
Em Yunir
Muhammad Firdaus
Yuniar Harris Prayitno
Nadira Nibras Taqiyya
Functional status, lymphocyte-to-monocyte ratio, and platelet-to-lymphocyte ratio as prognostic factors of one-year survival rate in elderly patients with advanced-stage non-small cell lung cancer
Cancer Treatment and Research Communications
Non-small-cell lung carcinoma
Geriatric
Elderly
Functional status
Lymphocyte-to-monocyte ratio
Platelet-to-lymphocyte ratio
title Functional status, lymphocyte-to-monocyte ratio, and platelet-to-lymphocyte ratio as prognostic factors of one-year survival rate in elderly patients with advanced-stage non-small cell lung cancer
title_full Functional status, lymphocyte-to-monocyte ratio, and platelet-to-lymphocyte ratio as prognostic factors of one-year survival rate in elderly patients with advanced-stage non-small cell lung cancer
title_fullStr Functional status, lymphocyte-to-monocyte ratio, and platelet-to-lymphocyte ratio as prognostic factors of one-year survival rate in elderly patients with advanced-stage non-small cell lung cancer
title_full_unstemmed Functional status, lymphocyte-to-monocyte ratio, and platelet-to-lymphocyte ratio as prognostic factors of one-year survival rate in elderly patients with advanced-stage non-small cell lung cancer
title_short Functional status, lymphocyte-to-monocyte ratio, and platelet-to-lymphocyte ratio as prognostic factors of one-year survival rate in elderly patients with advanced-stage non-small cell lung cancer
title_sort functional status lymphocyte to monocyte ratio and platelet to lymphocyte ratio as prognostic factors of one year survival rate in elderly patients with advanced stage non small cell lung cancer
topic Non-small-cell lung carcinoma
Geriatric
Elderly
Functional status
Lymphocyte-to-monocyte ratio
Platelet-to-lymphocyte ratio
url http://www.sciencedirect.com/science/article/pii/S2468294224000716
work_keys_str_mv AT ratnanurhayati functionalstatuslymphocytetomonocyteratioandplatelettolymphocyteratioasprognosticfactorsofoneyearsurvivalrateinelderlypatientswithadvancedstagenonsmallcelllungcancer
AT auliarizka functionalstatuslymphocytetomonocyteratioandplatelettolymphocyteratioasprognosticfactorsofoneyearsurvivalrateinelderlypatientswithadvancedstagenonsmallcelllungcancer
AT cleopasmartinrumende functionalstatuslymphocytetomonocyteratioandplatelettolymphocyteratioasprognosticfactorsofoneyearsurvivalrateinelderlypatientswithadvancedstagenonsmallcelllungcancer
AT noorwatisutandyo functionalstatuslymphocytetomonocyteratioandplatelettolymphocyteratioasprognosticfactorsofoneyearsurvivalrateinelderlypatientswithadvancedstagenonsmallcelllungcancer
AT arifhanafi functionalstatuslymphocytetomonocyteratioandplatelettolymphocyteratioasprognosticfactorsofoneyearsurvivalrateinelderlypatientswithadvancedstagenonsmallcelllungcancer
AT edyrizalwahyudi functionalstatuslymphocytetomonocyteratioandplatelettolymphocyteratioasprognosticfactorsofoneyearsurvivalrateinelderlypatientswithadvancedstagenonsmallcelllungcancer
AT hamzahshatri functionalstatuslymphocytetomonocyteratioandplatelettolymphocyteratioasprognosticfactorsofoneyearsurvivalrateinelderlypatientswithadvancedstagenonsmallcelllungcancer
AT annamiralubis functionalstatuslymphocytetomonocyteratioandplatelettolymphocyteratioasprognosticfactorsofoneyearsurvivalrateinelderlypatientswithadvancedstagenonsmallcelllungcancer
AT emyunir functionalstatuslymphocytetomonocyteratioandplatelettolymphocyteratioasprognosticfactorsofoneyearsurvivalrateinelderlypatientswithadvancedstagenonsmallcelllungcancer
AT muhammadfirdaus functionalstatuslymphocytetomonocyteratioandplatelettolymphocyteratioasprognosticfactorsofoneyearsurvivalrateinelderlypatientswithadvancedstagenonsmallcelllungcancer
AT yuniarharrisprayitno functionalstatuslymphocytetomonocyteratioandplatelettolymphocyteratioasprognosticfactorsofoneyearsurvivalrateinelderlypatientswithadvancedstagenonsmallcelllungcancer
AT nadiranibrastaqiyya functionalstatuslymphocytetomonocyteratioandplatelettolymphocyteratioasprognosticfactorsofoneyearsurvivalrateinelderlypatientswithadvancedstagenonsmallcelllungcancer